Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
C-X-C motif chemokine receptor 2 pseudogene 1 (CXCR2P1), corresponding to Ensembl gene ENSG00000277755, is a human gene classified as a pseudogene, meaning it does not encode a functional protein product. It is annotated as a pseudogene of the chemokine (C-X-C motif) receptor 2 (CXCR2), also known as the interleukin 8 receptor beta. As a pseudogene, CXCR2P1 is not considered a therapeutic target, nor is it associated with any pharmacological action or disease relevance as a direct protein product. Its presence is sometimes noted in genomic studies but it has no known direct cellular or signaling function. Pseudogenes may occasionally have regulatory RNA functions, but there are no established functions or disease associations for this particular pseudogene. The functional, druggable GPCR chemokine receptor is CXCR2 (C-X-C motif chemokine receptor 2, NCBI: 3579), not its pseudogene. Therefore, this entry is not a therapeutic target; it is a non-functional genetic segment derived from a chemokine receptor gene and should be indicated as an incorrect or non-actionable entry for any drug discovery or target validation purposes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on C-X-C motif chemokine receptor 2 pseudogene 1 (CXCR2P1).